Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17070204 | 0.96 | ESR2 (0.33) | ESR2FASN | |
| SCHEMBL19850822 | 0.93 | SLC6A3 (0.30) | — | |
| SCHEMBL17070239 | 0.93 | ESR2 (0.32) | ESR2FASN | |
| SCHEMBL20003624 | 0.92 | ESR2 (0.33) | ESR2FASN | |
| SCHEMBL19159677 | 0.92 | ESR2 (0.33) | ESR2FASN | |
| SCHEMBL18733825 | 0.92 | ESR2 (0.35) | ESR2FASN | |
| SCHEMBL17070242 | 0.90 | ESR2 (0.34) | ESR2FASN | |
| SCHEMBL14337495 | 0.90 | ESR2 (0.34) | ESR2FASN | |
| SCHEMBL17147788 | 0.89 | CYP3A4 (0.33) | — | |
| SCHEMBL16978420 | 0.89 | CYP3A4 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043782-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-11795398-B2 | Liquid-crystalline medium and liquid-crystal display comprising the same and compounds | MERCK PATENT GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| US-11788009-B2 | Liquid-crystalline medium for use in a switching element | MERCK PATENT GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| US-20230323209-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-11760931-B2 | Liquid-crystalline medium for use in a switching element | MERCK PATENT GMBH (DE) | 2023-09-19 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| US-20230068853-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2023-03-02 | — | — | US | disclosed |
| US-20230056437-A1 | AZO DYE | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-20230053362-A1 | DICHROIC DYE COMPOSITION | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-7303791-B2 | Liquid crystals having a terminal polar radical and a terminal CH3 group and simultaneously having very high specific resistances and low threshold voltages requiring a high clearing point and low rotational viscosity; matrices | MERCK PATENT GMBH (DE) | 2007-12-04 | — | — | US | disclosed |
| US-7303791-B2 | Liquid crystals having a terminal polar radical and a terminal CH3 group and simultaneously having very high specific resistances and low threshold voltages requiring a high clearing point and low rotational viscosity; matrices | MERCK PATENT GMBH (DE) | 2007-12-04 | — | — | US | disclosed |
| US-20070269614-A1 | Containing at least two nitrile-free mesogenic compounds, one of which contains rings including a phenyl ring llinked by at least one -CF2O- group; electrooptical dispalys | HECKMEIER MICHAEL | 2007-11-22 | — | — | US | disclosed |
| US-7291367-B2 | Liquid-crystalline compounds | MERCK PATENT GMBH (DE) | 2007-11-06 | — | — | US | disclosed |
| US-20070237907-A1 | PHOTOSTABLE LIQUID-CRYSTALLINE MEDIUM | MANABE ATSUTAKA | 2007-10-11 | — | — | US | disclosed |
| US-20070176144-A1 | Liquid crystal composition for bistable liquid crystal devices | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2007-08-02 | — | — | US | disclosed |
| US-7250198-B2 | For electrooptical display | MERCK PATENT GMBH (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7211302-B2 | Photostable liquid crystalline medium | MERCK PATENT GMBH (DE) | 2007-05-01 | — | — | US | disclosed |
| US-20070034828-A1 | Containing 3 directly connected rings: a fluorophenyl ring, a tetrahydropyran ring and either another tetrahydropyran ring or a 1,3-dioxane ring; electrooptical displays; | MERCK PATENT GMBH (DE) | 2007-02-15 | — | — | US | disclosed |
| US-7175891-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | ESR2 2503/4885FASN 2982/4885 |
| US-20230068853-A1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | CXCR1, PYM1, F11 | ESR2 2704/4885FASN 4069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.